Bernardo Cervantes: Microbial Therapeutics & Scaling Leadership

Update: 2025-05-22

Description

In this episode, we sit down with Dr. Bernardo Cervantes, leading the charge in microbiome science, with a mix of experience and insights:

Bernardo is the Co-Founder and COO of Concerto Biosciences, a biotech pioneering the development of microbial consortia-based therapeutics.
With a robust background in microbial engineering, Bernardo has dedicated his career to studying microbial interactions and microbiome health. His expertise spans sythetic biology and metabolic engineering.
Bernardo is internationally recognised for his contributions to microbiome science, particularly in translating complex microbial ecology into practical applications. His work at Concerto Biosciences has positioned him as a thought leader in developing next-generation microbial therapeutics.
Prior to co-founding Concerto Biosciences, Bernardo earned his PhD in Microbiology from the Massachusetts Institute of Technology (MIT).
Concerto has been active at major scientific conferences, including the 2024 BIO International Convention, where Concerto Biosciences was featured in the NIH Innovation Zone.

In this episode, we discuss the future of microbiome sciences, Bernardo’s key learnings throughout his career, how he’s adapted his leadership as one of three Co-Founders, management, a great opportunity within the market and a lot more. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: Leading Beyond The Lab

Instagram: Instagram (@arto.talent)

TikTok: artotalent on TikTok

Apple Podcasts: Leading Beyond The Lab

Website: Home

Youtube: ARTO Recruitment

Dr. Bernardo Cervantes

Chief Operations Officer at Concerto Biosciences

LinkedIn: https://www.linkedin.com/in/bernacularbio/

Lawrence Rose